Abstract PD13-01: PD13-01 Elacestrant in postmenopausal women with estrogen receptor positive and HER2-negative early breast cancer: primary efficacy and safety analysis of the preoperative, window of opportunity SOLTI-1905-ELIPSE trial

María Vidal, Meritxell Bellet Ezquerra, Claudette Falato et al.|Cancer Research|2023

Cited by 12